Hoebel and researchers in the department of psychology and the Princeton Neuroscience Institute have demonstrated patterns of craving and relapse, the third and final stage of addiction, that had ...

A drug most often prescribed for diabetes and obesity might soon be prescribed to curb one of the world’s hardest to quit ...

Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call ...

Dr. Harriet de Wit's groundbreaking 45-year journey bridges animal and human drug research, reshaping global understanding of consciousness CHICAGO, Illinois, USA, 26 August 2025 -- In a revealing ...

People often joke that their favorite snack is "like crack" or call themselves "chocoholics" in jest. But can someone really be addicted to food in the same way they could be hooked on substances such ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

Recent reports of the secondary effects of Ozempic, a new diabetes drug from Novo Nordisk, as well as its weight-loss drug Wegovy, can make one think that we should all be taking one of them. In ...

SKNY-1 was previously shown to achieve up to 30% weight loss, reverse nicotine craving, and preserve muscle mass in an animal model-and is designed to avoid the CNS side effects that halted earlier ...

“Ozempic personality” is a side effect reported by some users of popular GLP-1 obesity and diabetes medications. The term refers to a cluster of mental health issues, including increased anxiety, ...